Expression of the CD8αβ-heterodimer on CD8+ T lymphocytes in peripheral blood lymphocytes of human immunodeficiency virus- and human immunodeficiency virus+ individuals

Blood

Volumn 92, Issue 1, 1998, Pages 198-206

  Schmitz, Jörn E ^a   Forman, Meryl A ^b   Lifton, Michelle A ^b   Concepción Jr , Orlando ^b   Reimann, Keith A ^b   Crumpacker, Clyde S ^b   Daley, John F ^b   Gelman, Rebecca S ^b   Letvin, Norman L ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; INDINAVIR; LAMIVUDINE; ZIDOVUDINE; ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN EXPRESSION; ARTICLE; CELL ADHESION; CELL SURFACE; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; IMMUNOPHENOTYPING; LYMPHOCYTE COUNT; PERIPHERAL LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VIRUS REPLICATION; ANTIBODY SPECIFICITY; BIOSYNTHESIS; BLOOD; CD8+ T LYMPHOCYTE; CHEMISTRY; DIMERIZATION; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; ISOLATION AND PURIFICATION; VIROLOGY;

ANTIBODIES; ANTIBODY SPECIFICITY; ANTIGENS, CD8; CD8-POSITIVE T-LYMPHOCYTES; DIMERIZATION; HIV INFECTIONS; HIV-1; HUMANS; T-LYMPHOCYTE SUBSETS;

EID: 0032105515     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.1.198.413k13_198_206     Document Type: Article

References (45)

1. + lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234:1563, 1986
2. Tsubota H, Lord CI, Watkins DI, Morimoto C, Letvin NL: A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes. J Exp Med 169:1421, 1989
3. + T cells. Science 270:1811, 1995
4. + cells: Evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms. J Virol 71:3120, 1997
5. Walker BD, Chakrabarti S, Moss B, Paradis TJ, Flynn T, Durno AG, Blumberg RS, Kaplan JC, Hirsch MS, Schooley RT: HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 328:345, 1987
6. Hadida F, Parrot A, Kieny MP, Sadat-Sowti B, Mayaud C, Debre P, Autran B: Carboxyl-terminal and central regions of human immunodeficiency virus-1 NEF recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysis. J Clin Invest 89:53, 1992
7. Sethi KK, Naher H, Stroehmann I: Phenotypic heterogeneity of cerebrospinal fluid-derived HIV-specific and HLA-restricted cytotoxic T-cell clones. Nature 355:178, 1988
8. Yamamoto H, Miller MD, Tsubota H, Watkins DI, Mazzara GP, Stallard V, Panicali DL, Aldovini A, Young RA, Letvin NL: Studies of cloned simian immunodeficiency virus-specific T lymphocytes, gagspecific cytotoxic T lymphocytes exhibit a restricted epitope specificity. J Immunol 144:3385, 1990
9. Lohman BL, Miller CJ, McChesney MB: Antiviral cytotoxic T lymphocytes in vaginal mucosa of simian immunodeficiency virusinfected rhesus macaques. J Immunol 155:5855, 1995
10. Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G. Borkowsky W, Farthing C, Ho DD: Temporal association of cellular immune response with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 68:4650, 1994
11. + lymphocyte appears in lymph nodes of rhesus monkeys early after infection with simian immunodeficiency virus. J Gin Invest 88:1113, 1991
12. + lymphocyte response in acutely infected rhesus monkeys. J Virol 67:1707, 1993
13. Rinaldo C, Huang X-L, Fan Z, Ding M, Beltz L, Logar A, Panicali D, Mazzara G, Liebmann J, Cottrili M, Gupya P: High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J Virol 69:5838, 1995
14. + T- cells in HIV disease and following in vitro activation, in Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF (eds): Leucocyte Typing V, White Cell Differentiation Antigens (vol 1). New York, NY, Oxford, 1995, p 446
15. Giorgi JV: Phenotype and function of T cells in HIV disease, in Gupta S (ed): Immunology of HIV Infection. New York, NY, Plenum, 1996, p 181
16. Baume DM, Caligiuri MA, Manley TJ, Daley JF, Ritz J: Differential expression of CD8α and CD8β associated with MHC-restricted and non-MHC-restricted cytolytic effector cells. Cell Immunol 131:352, 1990
17. Moebius U, Kober G, Griscelli AL, Hercend T, Meuer SC: Expression of different CD8 isoforms on distinct human lymphocyte subpopulations. Eur J Immunol 21:1793, 1991
18. Norment AM, Littman DR: A second subunit of CD8 is expressed in human T cells. EMBO J 7:3433, 1988
19. Terry LA, DiSanto JP, Small TN, Flomemberg N: Differential expression and regulation of human CD8α and CD8β chains. Tissue Antigens 35:82, 1990
20. Berke G: The functions and mechanisms of action of cytolytic lymphocytes, in Paul WE (ed): Fundamental Immunology (ed 3). New York, NY, Raven, 1993, p 965
21. Reinherz EL, Schlossman SF: The differentiation and function of human T lymphocytes. Cell 19:821, 1980
22. Moretta L, Ciccone E, Ferrini S, Pelicci PG, Mingari MC, Zeromski J, Bottino C, Grossi C, Moretta A: Molecular and cellular analysis of human T lymphocytes expressing gd T-cell receptor. Immunol Rev 120:117, 1991
23. Robertson MJ, Ritz J: Biology and clinical relevance of human natural killer cells. Blood 76:2421, 1990
24. Alcover A: CDS cluster report, in Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Siverstein R, Springer T, Tedder TF, Todd RF (eds): Leucocyte Typing V, White Cell Differentiation Antigens (vol 1). New York, NY, Oxford, 1995, p 353
25. + T cell determinations in persons infected with human immunodeficiency virus (HIV). MMWR 46(No. RR2):1, 1997
26. Kagan JM, Mayall BH: Introduction to the NTAID guideline for flow cytometric immunophenotyping. Cytometry 14:701, 1993
27. Schenker EL, Hultin LE, Bauer KD, Ferbas J, Margolick JB, Giorgi JV: Evaluation of a dual-color flow cytometry immunophenotyping panel in a multicenter quality assurance program. Cytometry 14:307, 1993
28. Kruskal WH, Wallis WA: Use of ranks in one criterion variance analysis. JASA 47:583, 1952
29. Dunn OJ: Multiple comparisons using rank sums. Technometrics 6:241, 1964
30. Rosner B: Fundamentals of Biostatistics (ed 4). Belmont, CA, Duxbury, 1995
31. Wilcoxon F, Wilcox RA: Some rapid approximate statistical procedures. Lederle Laboratories, Pearl River, NY, 1964, p 59
32. Lanier LL, Le AM, Phillips JH, Warner NL, Babcock GF: Subpopulations of human natural killer cells defined by expression of the leu-7 (HNK-1) and leu-11 (NK-15) antigens. J Immunol 131:1789, 1983
33. Schenker EL, Hultin LE, Bauer KD, Ferbas J, Margolick JB, Giorgi JV: Evaluation of a dual-color flow cytometry immunophenotyping panel in a multicenter quality assurance program. Cytometry 14:307, 1993
34. Griffin JD, Hercend T, Beveridge R, Schlossman SF: Characterization of an antigen expressed by human natural killer cells. J Immunol 130:2947, 1983
35. Bikoue A, George F, Poncelet P, Mutin M, Janossy G, Sampol J: Quantitative analysis of leukocyte membrane antigen expression: Normal adult values. Cytometry 26:137, 1996
36. + cytotoxic T cells express CD38 and HLA-DR antigens. J Immunol 150:3070, 1993
37. Rocha B, Guy-Grand D, Vassalli P: Extrathymic T cell differentiation. Curr Opin Immunol 7:235, 1995
38. Roederer M, Herzenberg LA, Herzenberg LA: Changes in antigen densities on leukocyte subsets correlate with progression of HIV disease. Int Immunol 8:1, 1996
39. - T lymphocytes. Antigenic and functional properties. J Immunol 150:1147, 1993
40. Roederer M, Dubs JG, Anderson MT, Raju PA, Herzenberg LA, Herzenberg LA: CDS naive T cell counts decrease progressively in HIV-infected adults. J Clin Invest 95:2061, 1995
41. + T cell homeostasis and function in advanced HIV disease. Science 277:112, 1997
42. Kelleher AD, Carr A, Zaunders J, Cooper DA: Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir. J Infect Dis 173:321, 1996
43. + lymphocyte response to antiretroviral therapy of HIV infection. J Acquir Immune Defic Syndr 13:320, 1996
44. Casabo LG, Mamalaki C, Kioussis D, Zamoyska R: T cell activation results in physical modification of the mouse CD8β chain. J Immunol 152:397, 1994
45. Garcia KC, Scott CA, Brunmark A, Carbonet FR, Peterson PA, Wilson IA, Teyton L: CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes. Nature 384:577, 1996